Drug class
Acyclic nucleoside phosphonate antiviral; cytomegalovirus DNA polymerase inhibitor
Mechanism of action
Cidofovir is phosphorylated by cellular kinases to cidofovir diphosphate, which competitively inhibits viral DNA polymerases and becomes incorporated into viral DNA, suppressing viral DNA synthesis.
General use cases
- Treatment of cytomegalovirus (CMV) retinitis in patients with AIDS under the specific intravenous product indication; use is restricted by nephrotoxicity risk and requires probenecid and intravenous hydration per label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
